Traditional clinical trials often face challenges in participant engagement, data quality, and the speed of study launches, particularly when relying on conventional site-based methods. The need for more flexible and user-friendly solutions is critical to improving the efficiency and effectiveness of clinical research.

Curebase provides a modern eClinical platform designed to streamline clinical trials through improved data collection and enhanced participant experience. The platform supports both decentralized and site-based trials, offering tools for electronic patient-reported outcomes (ePRO), electronic consent (eConsent), and electronic data capture (EDC). By unifying the participant experience from prescreening to data submission, Curebase enables faster study launches, higher quality data, and stronger participant engagement. The platform's user-centered design and integrated features empower sponsors, CROs, and sites to conduct clinical research more efficiently and effectively.

ePRO/eCOA: Rapidly configurable endpoint collection with a focus on patient experience and targeted notification campaigns.

eConsent: Configurable consent workflows supporting multimedia content, multiple languages, and remote or site-based options.

Unified Participant Experience: Streamlines the patient journey from prescreening through data submission via a single mobile interface.

EDC: A unified data platform for hybrid and site-based studies with user-centric data collection and monitoring capabilities.

Study Designer: Enables complex study builds optimized for every step of the participant experience.

Integrated Engagement Tools: Keeps participants engaged and on track with in-app notifications and communication.

Curebase primarily serves sponsors, CROs (Contract Research Organizations), and clinical sites seeking to improve the efficiency, data quality, and participant engagement in their clinical trials.